SCHEMBL19036508

SCHEMBL19036508

Cn1c(=O)[nH]c(=O)c2c1[nH]n2CC(N)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.40
▸ ALDH1A1 P00352 4/20 0.40
▸ HPGD P15428 3/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ MAPT P10636 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ ALOX12 P18054 1/20 0.40
▸ KDM1A O60341 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.39
▸ GAA P10253 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ CASP3 P42574 1/20 0.37
▸ CASP8 Q14790 1/20 0.37
▸ LGMN Q99538 1/20 0.37
▸ DAO P14920 2/20 0.37
▸ MAPK10 P53779 1/20 0.37
▸ PDE5A O76074 1/20 0.35
▸ PDE1A P54750 1/20 0.35
▸ PDE1B Q01064 1/20 0.35
▸ PDE1C Q14123 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19036593 0.78 KDM1A (0.44) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL15075966 0.77 ALDH1A1 (0.47) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL19036537 0.73 KDM1A (0.40) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL15075715 0.72 EPHX2 (0.35) —
SCHEMBL19036641 0.61 KDM4E (0.50) KDM4EALDH1A1HPGDMAPTNPSR1
SCHEMBL20725308 0.55 ALDH1A1 (0.62) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL133905 0.54 HPGD (0.40) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL515834 0.54 KDM4E (0.54) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL10309075 0.54 GAA (0.57) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL1546631 0.53 EPHX2 (0.52) KDM4EALDH1A1HPGDHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3184527-A1 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL Hydra Biosciences, Inc. (US) 2017-06-28 — — EP disclosed
Send feedback